Ben Venue Laboratories is releasing a limited supply of preservative-free methotrexate to ease the shortage of the pediatric cancer drug, according to a company news release.
Ben Venue began distributing the drug to hospitals, oncology clinics and pediatric facilities yesterday. The goal is to satisfy near-term patient needs while other companies increase production of the drug.
The supply Ben Venue is releasing was produced before the company voluntarily suspended manufacturing in November 2011 to attend to manufacturing-related issues identified in FDA inspections, according to the release.
Senators Klobuchar and Collins Discuss Drug Shortages on Senate Floor
Institute for Safe Medication Practices Questions Medication Storage Rules
Ben Venue began distributing the drug to hospitals, oncology clinics and pediatric facilities yesterday. The goal is to satisfy near-term patient needs while other companies increase production of the drug.
The supply Ben Venue is releasing was produced before the company voluntarily suspended manufacturing in November 2011 to attend to manufacturing-related issues identified in FDA inspections, according to the release.
Related Articles on Drug Shortages:
Senator, Oncology Groups Urge Pharma to Boost Production of Pediatric Cancer DrugSenators Klobuchar and Collins Discuss Drug Shortages on Senate Floor
Institute for Safe Medication Practices Questions Medication Storage Rules